# A patient with multiple myeloma receiving daratumumab (anti-CD38) has weak panreactivity with all screening and panel cells at the antiglobulin phase. When the reagent cells are treated with 0.2 M dithiothreitol (DTT), all reactions become negative. The patient's K antigen status is K-negative. Which red cell selection is most appropriate?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=729643  
> language: ko  
> subject: Blood Banking · 수혈의학

## 문제

A patient with multiple myeloma receiving daratumumab (anti-CD38) has weak panreactivity with all screening and panel cells at the antiglobulin phase. When the reagent cells are treated with 0.2 M dithiothreitol (DTT), all reactions become negative. The patient's K antigen status is K-negative. Which red cell selection is most appropriate?

## 보기

1. Antiglobulin-crossmatch-compatible units that are also Fy(a-)
2. Antiglobulin-crossmatch-compatible units that are also Jk(a-)
3. Antiglobulin-crossmatch-compatible units that are also K-negative **✔ 정답**
4. Antiglobulin-crossmatch-compatible units that are also e-negative

**정답: 3**

## 해설

DTT denatures CD38 on reagent cells and removes daratumumab interference, but it also destroys Kell system antigens, so anti-K cannot be excluded with DTT-treated cells. A K-negative patient is therefore given K-negative units; Duffy, Kidd, and Rh antigens survive DTT and those antibodies are still excluded by the DTT-treated panel.

## 같은 주제 문제

- [A pretransfusion antibody screen is positive with both screening cells, but the patient's …](https://mymerci.kr/pages/nclex_q.php?qn_id=471837)
- [A previously transfused patient has a negative antibody screen, but one of three donor uni…](https://mymerci.kr/pages/nclex_q.php?qn_id=568477)
- [An antibody identification panel shows reactivity only with cells positive for the K antig…](https://mymerci.kr/pages/nclex_q.php?qn_id=568478)
- [A patient has anti-K and anti-Jka. If approximately 91 percent of donors are K negative an…](https://mymerci.kr/pages/nclex_q.php?qn_id=568481)
- [Pretreating panel cells with ficin or papain typically enhances reactivity of which antibo…](https://mymerci.kr/pages/nclex_q.php?qn_id=729642)
- [When excluding anti-Jkb during antibody identification, a nonreactive result with which pa…](https://mymerci.kr/pages/nclex_q.php?qn_id=729649)
- [An antibody panel tested by PEG-IAT gives these results (autocontrol negative). Cell 1: D+…](https://mymerci.kr/pages/nclex_q.php?qn_id=729650)
- [A hospital uses a validated computer (electronic) crossmatch. Which patient finding makes …](https://mymerci.kr/pages/nclex_q.php?qn_id=729661)

---

More free questions: [기출·모의문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._

